Mandatory Product Listing: Needed For US VMS Market, Not Mandatory In User Fee Bill – CRN

Establishing VMS products MPL as stated within legislation to re-authorize FDA user fee programs for drugs, biologics and medical device applications isn’t urgent enough to prevent passing user fee bill, says CRN chief Steve Mister.

Shutterstock

Mandatory product listing for dietary supplements is needed to improve US regulators’ oversight of the industry, says the Council for Responsible Nutrition.

However, imposing an MPL requirement for vitamin, mineral and supplement products as stated in provisions within legislation to re-authorize the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation